Laws
Delta-8 THC Is Legal, Shippable, and Gets You High, But What Does the FDA and NCBI Say About It Now?
Delta-8 tetrahydrocannabinol is a hallucinogenic compound seen in the cannabis Sativa plant, of which hemp and marijuana are two varieties. Delta-8 THC is just one in over 100 cannabinoids naturally gotten from the cannabis plant, although not in significant amounts from the plant. For this reason, concentrated amounts of delta-8 THC are commonly created from hemp-derived cannabidiol (CBD).
Consumers should be informed that the FDA has not examined or authorized products containing delta-8 THC for safe use in any situation. They should be kept out of the reach of children and dogs in particular since they may be sold in ways that endanger the public’s health.
Products that contain Delta-8 THC have become widely accessible in most parts of the US after the 2018 Farm Bill and later in 2020 where major products of hemp processing corporations, particularly where the use of delta-9-THC was still illegal or needed medical authorization.
According to NCBI research, there is a growing unregulated market for delta-8- THC, but there is no practical appraisal of the interest of the public in this compound.
Below are five things the FDA thinks you should know about delta-8 THC to protect those you care about and yourself from products that could pose health risks.
1. PRODUCTS WITH DELTA-8 THC ARE YET TO BE APPROVED OR EVALUATED BY THE FDA FOR SAFE CONSUMPTION AND MAY BE SOLD IN WAYS THAT ARE RISKY TO PUBLIC HEALTH.
The FDA is aware of the escalating worries regarding goods containing delta-8 THC that are now being sold offline and online. The FDA has not examined or cleared these items for safe use in any situation. Variations in product compositions and branding, the presence of other cannabinoids and terpenes, and varying delta-8 THC concentrations are some of the issues. Furthermore, some of these goods may simply be referred to as “hemp products,” which may confuse customers who mistakenly believe that “hemp” means “non-psychoactive.” The FDA is also worried about the rise in the number of products containing delta-8 THC that are advertised for therapeutic or medicinal uses while not having FDA approval. It is an infringement of federal law when unapproved products with unsupported therapeutic claims are sold, and since these items haven’t been shown to be safe or effective, they may also put consumers in danger. Because patients and other consumers might employ them in place of medications that have been proven effective in treating severe and even fatal conditions, fraudulent marketing of untested remedies raises substantial public health issues.
2. THE FDA HAS GOTTEN NEGATIVE REPORTS OF EVENTS INVOLVING PRODUCTS CONTAINING DELTA-8 THC. It
A total of 104 negative occurrences in patients who used delta-8 THC products from December 1, 2020, to February 28, 2022.
Reports indicate that 77% of these 104 negative occurrences involved adults, about 15% did not record age, and 8% involved pediatric patients who are less than 18 years old. Another 55% required assistance (e.g., evaluation by medical services) or admission into the hospital. And 66% characterized the negative occurrences after consumption of delta-8 THC-containing food products, for example, gummies and brownies. Some of these occurrences include confusion, hallucinations, anxiety, vomiting, tremor, dizziness, and loss of consciousness.
3. DELTA-8 THC HAS HALLUCINOGENIC AND INTOXICATING EFFECTS.
Similar to delta-9 THC (i.e., the substance responsible for the “high” individuals may feel from consuming cannabis), delta-8 THC possesses psychoactive and euphoric properties. The FDA is aware of media reports claiming that products containing delta-8 THC get users “high.” The FDA is especially worried because goods containing delta-8 THC likely expose consumers to significantly higher concentrations of the chemical than are found in raw hemp marijuana extracts. As a result, it is impossible to determine the level of safety for these products in people based on previous cannabis use.
4. PRODUCTS CONTAINING DELTA-8 THC USUALLY INVOLVE THE USE OF POTENTIALLY DANGEROUS CHEMICALS TO MAKE THE CONCENTRATIONS OF DELTA-8 THC CLAIMED IN THE MARKETPLACE.
Because hemp naturally contains relatively little delta-8 THC, other cannabinoids in hemp like CBD must be converted into it using extra chemicals (i.e., synthetic conversion). This process raises the following problems:
This chemical synthesis method is used by some producers to create delta-8 THC from potentially hazardous household substances. The final product’s hue may be altered using additional chemicals. Due to the chemicals utilized in the procedure, the finished delta-8 THC product may contain potentially dangerous by-products (contaminants), and there is uncertainty regarding other possible contaminants that may be present or created depending on the makeup of the original raw material. These compounds, including some utilized to generate (synthesize) delta-8 THC and the byproducts produced during synthesis, can be dangerous if ingested or inhaled.
5. PRODUCTS CONTAINING DELTA-8 THC MUST BE KEPT AWAY FROM CHILDREN AND PETS.
Producers are packing and branding these delta-8 THC-infused products in manners that may get the attention of children (chocolates, candies, cookies, gummies, etc.). These products are available for purchase online, as well as at various retail stores, such as gas stations and convenience stores, where there probably aren’t any age limitations on who can buy these products. There have been a lot of alerts to the poison control center affecting pediatric patients who all had been exposed to products containing delta-8 THC. In addition, poison control centers for animals have noted a quick overall growth in the accidental vulnerability of pets to these products. So, this product should be kept out of reach for children and pets. All CBD Products should be kept away from kids and pets.
BOTTOM LINE
NCBI found that with fewer side effects, delta-8 THC may offer many experiential advantages of delta-9 THC. Even though these investigations are hampered by the lawful statuses of both delta-8 THC and delta-9 THC, a future systematic study is required to verify participant accounts. Collaborations between the academic, governmental, and cannabis industry sectors may hasten the development of knowledge about Delta-8 THC and other cannabinoids.
The FDA clearly states that they have not yet carried out sufficient evaluation on products containing delta-8 THC and, as such, have not approved the sale or availability of such products for consumption, standing with the fact that delta-8 THC is a dangerous substance.
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
The Minnesota Supreme Court affirmed that cannabis odor does not constitute probable cause to search a vehicle.
If Minnesota police search a vehicle solely based upon the smell of pot, they can’t justify searching a vehicle, even if there is evidence found of other alleged crimes. Even after appealing a lower court decision to suppress the evidence—twice—the Minnesota Supreme Court agreed, and the dismissal of his charges stands.
In a ruling filed regarding a case the State of Minnesota Court of Appeals on Sept. 13, the Minnesota Supreme Court affirmed that cannabis odor does not constitute probable cause to search a vehicle.
The case has been ongoing for two years. On July 5, 2021, just before 10 p.m., a Litchfield police officer stopped a car for an obscure local law: the light bar mounted on the vehicle’s grill had more auxiliary driving lights than are permitted under Minnesota law. The officer asked the driver, Adam Lloyd Torgerson, for his license and registration. Torgerson, his wife, and his child were present in the vehicle. The officer stated that he smelled pot and asked Torgerson if there was any reason for the odor, which he initially denied. But cops found a lot more than just pot.
A backup officer was called in. The couple denied possessing any pot, but Torgerson admitted to smoking weed in the past. The second officer stated that the weed odor gave them probable cause to search the vehicle and ordered them to exit the vehicle. The first officer searched the vehicle and found a film canister, three pipes, and a small plastic bag in the center console. The plastic bag contained a white powder and the film canister contained meth, which was confirmed in a field test.
Torgenson was charged with possession of meth pipe in the presence of a minor and fifth-degree possession of a controlled substance after the unwarranted search of Torgerson’s vehicle.
Police Aren’t Allowed to Do That, Multiple Courts Rule
But the search had one major problem—cops weren’t searching for a meth pipe. They only searched his car because they could smell pot, and the meth and paraphernalia were a surprise for everyone. Still, they had no grounds to search the vehicle. The man’s charges were later dismissed after the district court determined the odor of cannabis alone was insufficient basis for probable cause to search the vehicle, regardless of whatever other drug paraphernalia they found.
The state appealed the case, but the Minnesota Court of Appeals affirmed the district court’s decision. The case was appealed a second time, this time to the Minnesota Supreme Court, which agreed with the lower court’s ruling.
“This search was justified only by the odor of marijuana emanating from the vehicle,” the Minnesota Supreme Court decision reads. “Torgerson moved to suppress the evidence found during the search, arguing that the odor of marijuana, alone, is insufficient to create the requisite probable cause to search a vehicle under the automobile exception to the warrant requirement. The district court granted Torgerson’s motion, suppressed the evidence, and dismissed the complaint. The State appealed. The court of appeals affirmed the district court’s suppression order. Because we conclude that the odor of marijuana emanating from a vehicle, alone, is insufficient to create the requisite probable cause to search a vehicle under the automobile exception to the warrant requirement, we affirm.”
It amounts to basic human rights that apply—regardless of whether or not a person is addicted to drugs.
Other States do Precisely the Same Regarding Pot Odor as Probably Cause
An Illinois judge ruled in 2021 that the odor of cannabis is not sufficient grounds for police to search a vehicle without a warrant during a traffic stop.
Daniel J. Dalton, Associate Judge of the 14th Judicial Circuit, issued a ruling in response to a motion to suppress evidence in the case of Vincent Molina, a medical cannabis patient arrested for cannabis possession last year.
In that case, Molina was arrested despite the decriminalization of small amounts of cannabis in Illinois in 2019 with the passage of the Illinois Cannabis Regulation and Tax Act.
In some states, the issue of probable cause and cannabis was defined through bills.
Last April, the Maryland House of Delegates approved a bill that reduces the penalties for public cannabis consumption and bars police from using the odor of cannabis as the basis for the search of an individual or auto. Under Maryland’s House Bill 1071, law enforcement officers would be prohibited from using the odor of raw or burnt cannabis as probable cause to search a person or vehicle.
The rulings represent the rights of citizens when they are pulled over by police, even if there are hard drugs involved.
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy